ScoreWhy is Oxygenta Pharmaceutical Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 21.21% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
Flat results in Mar 26
- NO KEY NEGATIVE TRIGGERS
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 21-May-26 and has generated -6.95% returns since then
- A key technical factor - Bollinger Band has been Bearish since 21 May 2026
4
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -44.84%, its profits have fallen by -1738%
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -44.84% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Oxygenta Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Oxygenta Pharma
-43.09%
-0.77
58.30%
Sensex
-1.65%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.83%
EBIT Growth (5y)
-227.03%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.07
Net Debt to Equity (avg)
-2.52
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
-20.91%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
37
Price to Book Value
-4.83
EV to EBIT
-31.09
EV to EBITDA
-39.26
EV to Capital Employed
4.85
EV to Sales
2.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.34%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(Q)
At Rs 37.00 cr has Grown at 144.55%
PBDIT(Q)
Highest at Rs 0.55 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 1.49%
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Oxygenta Pharma
Net Sales - Quarterly
At Rs 37.00 cr has Grown at 144.55%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.55 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 1.49% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
